Total Assets Summary of Novo Nordisk A/S

Novo Nordisk A/S's latest annual total assets in 2023 was 314.48 Billion DKK , up 30.35% from previous year.
Novo Nordisk A/S's latest quarterly total assets in 2024 Q1 was 298.92 Billion DKK , down -4.95% from previous quarter.
Novo Nordisk A/S reported annual total assets of 241.25 Billion DKK in 2022, up 24.03% from previous year.
Novo Nordisk A/S reported annual total assets of 194.5 Billion DKK in 2021, up 34.22% from previous year.
Novo Nordisk A/S reported quarterly total assets of 369.38 Billion DKK for 2024 Q2, up 23.57% from previous quarter.
Novo Nordisk A/S reported quarterly total assets of 250.02 Billion DKK for 2023 Q1, up 3.63% from previous quarter.

Annual Total Assets Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Total Assets of Novo Nordisk A/S (2023 - 1989)

Year	Total Assets	Total Assets Growth
2023	314.48 Billion DKK	30.35%
2022	241.25 Billion DKK	24.03%
2021	194.5 Billion DKK	34.22%
2020	144.92 Billion DKK	15.37%
2019	125.61 Billion DKK	13.4%
2018	110.76 Billion DKK	8.22%
2017	102.35 Billion DKK	4.94%
2016	97.53 Billion DKK	6.25%
2015	91.79 Billion DKK	19.12%
2014	77.06 Billion DKK	9.56%
2013	70.33 Billion DKK	7.11%
2012	65.66 Billion DKK	1.5%
2011	64.69 Billion DKK	5.37%
2010	61.4 Billion DKK	12.17%
2009	54.74 Billion DKK	7.92%
2008	50.72 Billion DKK	6.13%
2007	47.79 Billion DKK	6.93%
2006	44.69 Billion DKK	6.68%
2005	41.89 Billion DKK	11.14%
2004	37.69 Billion DKK	9.3%
2003	34.48 Billion DKK	9.65%
2002	31.45 Billion DKK	9.1%
2001	28.82 Billion DKK	17.19%
2000	24.6 Billion DKK	-20.75%
1999	31.04 Billion DKK	13.54%
1998	27.34 Billion DKK	6.44%
1997	25.68 Billion DKK	22.04%
1996	21.04 Billion DKK	4.47%
1995	20.14 Billion DKK	-4.66%
1994	21.12 Billion DKK	9.82%
1993	19.24 Billion DKK	14.69%
1992	16.77 Billion DKK	9.85%
1991	15.27 Billion DKK	22.18%
1990	12.49 Billion DKK	7.2%
1989	11.66 Billion DKK	26.38%

Year	Total Assets	Total Assets Growth
2024 Q1	298.92 Billion DKK	-4.95%
2024 Q2	369.38 Billion DKK	23.57%
2023 Q1	250.02 Billion DKK	3.63%
2023 Q2	280.75 Billion DKK	12.29%
2023 Q4	314.48 Billion DKK	4.79%
2023 Q3	300.1 Billion DKK	6.89%
2023 FY	314.48 Billion DKK	30.35%
2022 Q1	197.13 Billion DKK	1.35%
2022 Q4	241.25 Billion DKK	-0.65%
2022 Q3	242.83 Billion DKK	10.92%
2022 Q2	218.92 Billion DKK	11.05%
2022 FY	241.25 Billion DKK	24.03%
2021 Q3	174.08 Billion DKK	10.11%
2021 Q4	194.5 Billion DKK	11.73%
2021 FY	194.5 Billion DKK	34.22%
2021 Q2	158.09 Billion DKK	11.82%
2021 Q1	141.38 Billion DKK	-2.44%
2020 FY	144.92 Billion DKK	15.37%
2020 Q4	144.92 Billion DKK	3.55%
2020 Q1	126.25 Billion DKK	0.51%
2020 Q2	136.12 Billion DKK	7.81%
2020 Q3	139.94 Billion DKK	2.81%
2019 FY	125.61 Billion DKK	13.4%
2019 Q3	124.9 Billion DKK	5.94%
2019 Q4	125.61 Billion DKK	0.56%
2019 Q2	117.9 Billion DKK	7.06%
2019 Q1	110.13 Billion DKK	-0.57%
2018 Q3	101.89 Billion DKK	-1.31%
2018 Q2	103.24 Billion DKK	10.36%
2018 Q4	110.76 Billion DKK	8.71%
2018 Q1	93.55 Billion DKK	-8.59%
2018 FY	110.76 Billion DKK	8.22%
2017 FY	102.35 Billion DKK	4.94%
2017 Q4	102.35 Billion DKK	4.56%
2017 Q3	97.89 Billion DKK	0.07%
2017 Q2	97.82 Billion DKK	3.83%
2017 Q1	94.21 Billion DKK	-3.41%
2016 FY	97.53 Billion DKK	6.25%
2016 Q4	97.53 Billion DKK	11.68%
2016 Q2	88.26 Billion DKK	7.16%
2016 Q3	87.34 Billion DKK	-1.05%
2016 Q1	82.36 Billion DKK	-10.27%
2015 Q1	77.45 Billion DKK	0.51%
2015 FY	91.79 Billion DKK	19.12%
2015 Q4	91.79 Billion DKK	7.75%
2015 Q3	85.19 Billion DKK	4.77%
2015 Q2	81.31 Billion DKK	4.98%
2014 Q4	77.06 Billion DKK	8.11%
2014 Q2	63.68 Billion DKK	0.7%
2014 Q1	63.24 Billion DKK	-10.09%
2014 FY	77.06 Billion DKK	9.56%
2014 Q3	71.28 Billion DKK	11.94%
2013 Q2	64.28 Billion DKK	2.95%
2013 Q3	68.13 Billion DKK	5.98%
2013 Q4	70.33 Billion DKK	3.23%
2013 FY	70.33 Billion DKK	7.11%
2013 Q1	62.44 Billion DKK	-4.91%
2012 Q3	66.62 Billion DKK	9.25%
2012 Q1	61.21 Billion DKK	-5.39%
2012 Q2	60.97 Billion DKK	-0.38%
2012 Q4	65.66 Billion DKK	-1.43%
2012 FY	65.66 Billion DKK	1.5%
2011 FY	64.69 Billion DKK	5.37%
2011 Q4	64.69 Billion DKK	4.33%
2011 Q1	59 Billion DKK	-3.91%
2011 Q3	62.01 Billion DKK	0.79%
2011 Q2	61.52 Billion DKK	4.28%
2010 Q3	57.16 Billion DKK	0.2%
2010 Q4	61.4 Billion DKK	7.42%
2010 Q2	57.04 Billion DKK	5.34%
2010 Q1	54.15 Billion DKK	-1.07%
2010 FY	61.4 Billion DKK	12.17%
2009 Q1	50.2 Billion DKK	-1.03%
2009 FY	54.74 Billion DKK	7.92%
2009 Q4	54.74 Billion DKK	4.09%
2009 Q3	52.58 Billion DKK	2.62%
2009 Q2	51.24 Billion DKK	2.07%
2008 Q3	48.95 Billion DKK	0.92%
2008 Q4	50.72 Billion DKK	3.63%
2008 Q1	47.48 Billion DKK	-0.64%
2008 FY	50.72 Billion DKK	6.13%
2008 Q2	48.5 Billion DKK	2.13%
2007 Q4	47.79 Billion DKK	-1.26%
2007 Q3	48.4 Billion DKK	0.16%
2007 Q1	44.74 Billion DKK	0.12%
2007 Q2	48.33 Billion DKK	8.01%
2007 FY	47.79 Billion DKK	6.93%
2006 FY	44.69 Billion DKK	6.68%
2006 Q4	44.69 Billion DKK	2.12%
2006 Q3	43.76 Billion DKK	1.39%
2006 Q2	43.16 Billion DKK	4.49%
2006 Q1	41.31 Billion DKK	-1.39%
2005 FY	41.89 Billion DKK	11.14%
2005 Q4	41.89 Billion DKK	4.34%
2005 Q3	40.15 Billion DKK	6.6%
2005 Q2	37.66 Billion DKK	3.14%
2005 Q1	36.51 Billion DKK	-3.12%
2004 FY	37.69 Billion DKK	9.3%
2004 Q1	33.61 Billion DKK	-2.54%
2004 Q3	35.54 Billion DKK	3.78%
2004 Q2	34.24 Billion DKK	1.89%
2004 Q4	37.69 Billion DKK	6.06%
2003 Q4	34.48 Billion DKK	0.0%
2003 FY	34.48 Billion DKK	9.65%
2002 Q4	31.45 Billion DKK	0.0%
2002 FY	31.45 Billion DKK	9.1%
2001 Q4	28.82 Billion DKK	0.0%
2001 FY	28.82 Billion DKK	17.19%
2000 FY	24.6 Billion DKK	-20.75%
2000 Q4	24.6 Billion DKK	0.0%
1999 Q4	31.04 Billion DKK	0.0%
1999 FY	31.04 Billion DKK	13.54%
1998 FY	27.34 Billion DKK	6.44%
1998 Q4	27.34 Billion DKK	0.0%
1997 FY	25.68 Billion DKK	22.04%
1997 Q4	25.68 Billion DKK	0.0%
1996 Q4	21.04 Billion DKK	0.0%
1996 FY	21.04 Billion DKK	4.47%
1995 FY	20.14 Billion DKK	-4.66%
1995 Q4	20.14 Billion DKK	0.0%
1994 Q4	21.12 Billion DKK	0.0%
1994 FY	21.12 Billion DKK	9.82%
1993 FY	19.24 Billion DKK	14.69%
1993 Q4	19.24 Billion DKK	0.0%
1992 FY	16.77 Billion DKK	9.85%
1992 Q4	16.77 Billion DKK	0.0%
1991 FY	15.27 Billion DKK	22.18%
1991 Q4	15.27 Billion DKK	0.0%
1990 Q4	12.49 Billion DKK	0.0%
1990 FY	12.49 Billion DKK	7.2%
1989 FY	11.66 Billion DKK	26.38%
1989 Q4	11.66 Billion DKK	0.0%

Peer Total Assets Comparison of Novo Nordisk A/S

Name	Total Assets	Total Assets Difference
ADC Therapeutics SA	354.78 Million USD	-88542.039%
Alto Neuroscience, Inc.	86.62 Million USD	-362930.429%
Annovis Bio, Inc.	10.2 Million USD	-3080600.107%
Biohaven Pharmaceutical Holding Company Ltd.	513.21 Million USD	-61177.99%
Ginkgo Bioworks Holdings, Inc.	1.66 Billion USD	-18784.169%
Nuvation Bio Inc.	621.48 Million USD	-50502.429%
Nuvation Bio Inc.	621.48 Million USD	-50502.429%
Arcus Biosciences, Inc.	1.09 Billion USD	-28620.183%
Theriva Biologics, Inc.	60.21 Million USD	-522206.555%
Zymeworks Inc.	580.88 Million USD	-54039.581%

Global Stocks Search

Novo Nordisk A/S (NVO)

Total Assets Summary of Novo Nordisk A/S

Annual Total Assets Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Total Assets of Novo Nordisk A/S (2023 - 1989)

Peer Total Assets Comparison of Novo Nordisk A/S